Centrus Energy (LEU) Investor presentation summary

Strategic positioning and market opportunity

• Only American uranium enrichment company with proven, deployment-ready technology, uniquely positioned for both national security and commercial supply chains.

• Robust $4.5bn backlog with contracts extending through 2040, providing strong long-term cash flow visibility.

• First-mover advantage as the only HALEU enricher in the Western world, addressing advanced reactor market needs.

• Signed Department of Energy awards and bipartisan support to repatriate the nuclear supply cycle.

• Operational footprint and infrastructure allow for significant expansion to meet growing LEU and HALEU demand.

Financial performance and outlook

• Market capitalization of $3.2bn, with 2025 revenue at $448.7mm and net income of $77.3mm.

• $1.9bn cash on balance sheet as of June 2026, supporting commercial-scale ramp-up.

• 13% revenue CAGR from 2020-2025 and 5.6% annual net income growth.

• $3.0bn growing backlog of contingent LEU & HALEU sales commitments.

• 2026 guidance projects $450-500mm revenue and $350-500mm capital deployed, with significant workforce additions.

Operational progress and expansion

• Began HALEU enrichment operations in October 2023, delivering ahead of schedule and under budget.

• Completed Phase II of DOE contract in 2025, delivering 900 kg of HALEU UF6.

• Manufacturing and assembly capacity in Oak Ridge and Piketon supports rapid scale-up, with first full cascade expected online in 2029.

• Only U.S. facility licensed to enrich HALEU and one of two licensed for LEU.

• Partnerships with Fluor, Palantir, and Geiger Brothers identified $300M in cost savings and efficiencies.